Prestige Consumer Healthcare Inc.
PBHCIK 0001295947 · Pharmaceutical Preparations · NYSE
- Prestige Brands Holdings, Inc. (until 2018-08-10)
Revenue (TTM)
$1.1B
−4.3% YoY
FY May 2026
Net Income (TTM)
$197.41M
−11.3% YoY
FY May 2026
EPS Diluted (TTM)
$4.00
−8.9% YoY
FY May 2026
Gross Margin
55.6%
FY May 2026
Operating Margin
29.7%
FY May 2026
Net Margin
18.0%
FY May 2026
Free Cash Flow (TTM)
$235.61M
FY May 2026
Cash
$63.87M
FY May 2026
Total Debt
$1.01B
FY May 2026
Shares Outstanding
47.37M sh
FY May 2026